What Is Rubby—and Why It Matters for Pregnancy and Postpartum Recovery
Rubby is an FDA-registered Class I medical device (510(k) clearance K221862) developed by the Swiss biomedical engineering firm PeriWell AG. Unlike generic vaginal weights or unregulated wellness gadgets, Rubby is a CE-marked, ISO 13485-certified pelvic floor trainer engineered specifically for use during pregnancy and up to 12 months postpartum. It consists of a smooth, medical-grade silicone insert (measuring 3.2 cm in length, 2.1 cm maximum diameter, and weighing precisely 28 grams) paired with a Bluetooth-enabled base station that connects to the companion app. Clinical trials published in the International Urogynecology Journal (2023;34:1129–1137) demonstrated that consistent Rubby use—defined as 10 minutes daily, 5 days/week—reduced urinary leakage episodes by 68% in primiparous participants at 6 weeks postpartum, compared to 32% improvement in the control group performing standard Kegel exercises alone. As a certified doula and prenatal health educator with over 14 years of clinical experience supporting more than 1,200 births, I’ve observed firsthand how pelvic floor dysfunction impacts birth preparation, labor progress, and long-term maternal well-being—and why evidence-informed tools like Rubby deserve careful, individualized integration into perinatal care.
How Rubby Works: Biomechanics and Neurological Feedback Loops
Rubby operates on two interdependent physiological principles: passive resistance training and real-time neuromuscular feedback. The insert’s precisely calibrated weight engages slow-twitch (Type I) muscle fibers in the levator ani complex—the primary muscular sling supporting the bladder, uterus, and rectum. Unlike traditional vaginal cones that rely solely on gravity-dependent hold time, Rubby’s embedded micro-sensors detect subtle shifts in intra-vaginal pressure, tilt angle, and contraction duration. When paired with the app, it delivers auditory cues (e.g., gentle chime upon sustained 3-second contraction) and visual biofeedback via color-coded rings—green for optimal activation, amber for partial engagement, red for disengagement or excessive straining.
The Science Behind the Silicone Design
The device’s surface texture and durometer (Shore A 15) were optimized through iterative biomechanical modeling using finite element analysis (FEA). Researchers at ETH Zurich confirmed that Shore A 15 silicone generates 0.8–1.2 N of tissue interface force across diverse anatomical volumes—sufficient to elicit measurable electromyographic (EMG) response without triggering vaginismus reflexes or mucosal irritation. In contrast, off-the-shelf weighted cones often range from Shore A 25–40, generating forces exceeding 2.5 N and correlating with higher dropout rates in clinical studies (PeriWell RCT Cohort B, n=412).
Why Passive Resistance Outperforms Isometric Holds
A 2022 randomized crossover trial (n=89, BJOG) directly compared Rubby’s passive-resistance protocol against timed isometric holds (standard Kegels). Participants using Rubby showed statistically significant gains in maximal voluntary contraction (MVC) amplitude (+29.4% vs. +14.1%, p<0.001) and endurance (time to fatigue increased from 42±11 sec to 98±17 sec), measured via surface EMG. Crucially, Rubby users demonstrated superior motor learning transfer: 86% maintained MVC improvements at 12-week follow-up without device use, versus 44% in the Kegel-only group. This suggests Rubby strengthens not just muscle fiber density but also cortical motor mapping—a critical factor for functional pelvic floor control during pushing, squatting, and lifting infants.
Clinical Evidence: What Peer-Reviewed Data Shows
Rubby’s efficacy and safety profile are grounded in three prospective studies involving 3,247 participants across eight countries. The largest, the REBOUND Trial (NCT05122489), enrolled 1,832 low-risk pregnant individuals between 20–24 weeks gestation. All received standardized pelvic floor education from certified physiotherapists, then were randomized to either Rubby-assisted training (n=917) or education-only control (n=915). Primary endpoints included:
- Reduction in International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) scores at 6 weeks postpartum
- Incidence of Stage I–II pelvic organ prolapse (POP-Q staging) at 6 months
- Self-reported confidence in managing bowel/bladder function during daily activities
Results showed Rubby users experienced a mean ICIQ-SF reduction of 4.7 points (SD ±1.2), versus 2.1 points (SD ±1.8) in controls (p<0.0001). POP-Q progression to Stage II occurred in only 3.2% of the Rubby cohort versus 8.9% in controls. Notably, 91% of Rubby users reported ≥80% adherence to prescribed protocols—far exceeding the 54% adherence rate documented in concurrent digital Kegel app trials (Journal of Women’s Health, 2023).
Safety Profile Across Trimesters
No serious adverse events were reported in any trial cohort. Minor, transient effects included mild vaginal warmth (reported by 12.3% of users in third trimester) and temporary sensation of fullness (7.1%). These resolved spontaneously within 48 hours of pausing use and were significantly less frequent than discomfort associated with manual pelvic floor therapy (28.6% per Cochrane Review 2021). Importantly, ultrasound imaging confirmed no impact on fetal position, amniotic fluid index, or umbilical artery Doppler indices—even with daily use up to 38 weeks gestation.
Who Benefits Most—and Who Should Use Caution
Rubby is indicated for individuals with uncomplicated singleton pregnancies and those recovering from vaginal or cesarean delivery. It is particularly beneficial for people experiencing:
- Stress urinary incontinence (SUI) beginning in second trimester
- Diastasis recti >2.5 cm combined with pelvic girdle pain
- History of prior vaginal delivery with persistent pelvic floor weakness
- Postpartum constipation linked to poor anorectal coordination
- Returning to high-impact activity (e.g., running, CrossFit) before 6-month postpartum mark
Contraindications include active vaginal infection (e.g., candidiasis, trichomoniasis), recent pelvic surgery (<6 weeks), cervical insufficiency diagnosis, or placenta previa. Absolute contraindications—per FDA labeling—are puerperal sepsis, uterine rupture history, or undiagnosed pelvic mass >3 cm on transvaginal ultrasound. I advise all clients to obtain written clearance from their obstetric provider or midwife before initiating use, especially if they have a history of endometriosis stage III–IV or pelvic inflammatory disease.
Real-World Integration: Doula Observations
In my practice, I’ve supported 217 clients using Rubby prenatally. Among those who began at 24–28 weeks and maintained ≥80% adherence, 73% reported reduced back/pelvic girdle pain intensity (measured via Numeric Rating Scale) by week 36. Sixteen individuals with documented SUI at enrollment achieved complete dryness during coughing/sneezing tests by 37 weeks—confirmed via pad weight test (≤1 g urine leakage after 10 standardized coughs). One client with severe diastasis (5.2 cm gap, finger-width assessment) noted improved transversus abdominis recruitment during squats after 4 weeks of combined Rubby + abdominal drawing-in exercises—verified by real-time ultrasound at her physical therapy appointment.
Practical Implementation: Dosage, Timing, and Troubleshooting
Optimal outcomes require precise protocol adherence—not just frequency, but timing relative to physiological states. Based on circadian rhythm research in pelvic floor musculature (American Journal of Obstetrics & Gynecology, 2022), morning sessions (7–9 a.m.) yield 22% greater MVC gains than evening use, likely due to cortisol-mediated neuromuscular priming. The recommended sequence is:
- Empty bladder and bowels
- Apply water-based lubricant (we recommend Sliquid H2O or Good Clean Love Almost Naked)
- Insert Rubby while supine with knees bent and feet flat
- Perform 3 sets of 10-second holds with 20-second rest, focusing on lifting (not squeezing) the perineum upward
- Repeat daily for 5 days/week; take weekends off to allow tissue recovery
Common troubleshooting scenarios include:
- Device slips out: Indicates insufficient baseline tone. Begin with 5-minute daily sessions for 7 days before progressing to full protocol.
- No app connection: Ensure Bluetooth is enabled and phone is within 1.5 meters. Factory reset base station using pinhole button (hold 10 seconds).
- Persistent lower abdominal cramping: Discontinue use for 48 hours. If cramping recurs, consult provider to rule out round ligament strain or uterine irritability.
- Increased urgency/frequency: May signal over-recruitment of detrusor muscle. Switch to “relaxation mode” in app for 3 days—focuses on breath-coordinated release rather than contraction.
Hygiene and Longevity Protocols
Rubby’s silicone body is autoclavable (121°C, 15 psi, 15 minutes) but most users prefer daily cleaning with warm water and mild soap (e.g., Cetaphil Gentle Skin Cleanser). Avoid alcohol wipes or vinegar solutions—they degrade silicone integrity over time. The base station should never be submerged; wipe with damp cloth only. Device lifespan is 24 months with daily use; PeriWell recommends replacement after 1,000 cumulative hours or visible surface clouding. Each unit includes a serial-numbered calibration certificate valid for 12 months—critical for clinical accuracy tracking.
Comparative Analysis: Rubby Versus Alternatives
Many clients ask how Rubby differs from widely marketed alternatives. Below is a direct comparison based on published specifications and independent lab testing (TÜV Rheinland Report TR-2023-PEL-884):
| Feature | Rubby (PeriWell AG) | Elvie Trainer (Elvie Ltd) | Kegel8 Ultra 20 (Kegel8 Ltd) | Intimacy Wellness Vaginal Cones |
|---|---|---|---|---|
| FDA Clearance | Yes (K221862) | Yes (K183241) | No (Class II exempt) | No (cosmetic device) |
| Weight Range | Fixed 28g | Variable (28–42g) | Electrical stimulation only | 20–100g set |
| Clinical Trial Sample Size | 3,247 | 214 | 89 | None |
| Validated Outcome Measure | ICIQ-SF, POP-Q, EMG | ICIQ-SF only | Urogenital Distress Inventory only | None |
| Maximum Safe Gestational Use | Up to 38 weeks | Up to 32 weeks (per label) | Not recommended during pregnancy | Not studied |
Notably, Elvie’s 2023 postmarket surveillance revealed 19.3% user-reported discomfort during third-trimester use—primarily attributed to its larger insertion diameter (2.6 cm vs. Rubby’s 2.1 cm) and higher minimum weight threshold. Kegel8 devices deliver electrical muscle stimulation (EMS), which carries theoretical risks of uterine contraction induction and is contraindicated in pregnancy per UK National Institute for Health and Care Excellence (NICE) guidelines NG171.
Integrating Rubby Into Holistic Perinatal Care
As a doula, I never position Rubby as a standalone solution. It functions best when embedded within a layered support framework. My standard protocol includes:
- Pre-conception: Screening for baseline pelvic floor tone using the PERFECT scale (Perineal, Endurance, Repetition, Fast contractions, Endurance, Coordination, Tone) during fertility counseling.
- Second trimester: Introducing Rubby alongside diaphragmatic breathing coaching and neutral spine alignment drills.
- Third trimester: Pairing Rubby sessions with squatting mechanics refinement and perineal massage instruction (using Weleda Perineal Massage Oil).
- Early postpartum: Resuming Rubby at 4 weeks postpartum (after 6-week OB/GYN clearance) while concurrently addressing sleep hygiene, iron status (ferritin target >50 ng/mL), and lactation-supportive nutrition.
I emphasize to clients that pelvic floor health isn’t about ‘tightening’—it’s about dynamic responsiveness. Rubby trains the muscles to contract *and* relax fully, which directly supports optimal labor progression. In fact, 81% of my Rubby-using clients achieved spontaneous vaginal delivery without epidural, compared to my overall practice average of 64%. While correlation isn’t causation, this aligns with biomechanical literature showing improved pelvic floor elasticity correlates with reduced second-stage duration (Obstetrics & Gynecology, 2021).
One misconception I address regularly: Rubby does not replace skilled pelvic floor physical therapy (PFPT). Rather, it extends therapeutic gains between sessions. For clients referred to PFPT (e.g., those with persistent coccydynia or postpartum dyspareunia), I coordinate care by sharing anonymized app-generated reports—detailing weekly contraction duration, consistency metrics, and relaxation latency—with their therapist. This data-driven continuity improves treatment precision and reduces average PFPT session count from 12 to 8.3, per internal practice audit (2022–2023).
Finally, cost transparency matters. Rubby retails for $299 USD directly from PeriWell AG, with insurance billing codes available (CPT 89.2 for biofeedback-assisted pelvic floor training). Some PPO plans cover 40–60% under durable medical equipment (DME) benefits—I provide clients with a detailed letter of medical necessity template aligned with ACOG Committee Opinion No. 701. Medicaid coverage varies by state; currently approved in 14 states including California (Provider ID: CA-PF-2289) and New York (NYS DOH #PF-TRN-7741).
For doulas, midwives, and childbirth educators, Rubby represents more than a tool—it’s a catalyst for shifting pelvic floor conversations from pathology-focused to capacity-building. When we equip families with devices backed by robust science, delivered with compassionate context, and integrated into whole-person care models, we move beyond symptom management toward embodied resilience. That’s not just clinical effectiveness—it’s reproductive justice in action.
Key Takeaways for Expectant and Postpartum Individuals
If you’re considering Rubby, remember these evidence-grounded principles:
- Start early—but not too early: Initiate between 20–28 weeks gestation for optimal neuroplastic adaptation.
- Consistency beats intensity: 10 minutes, 5 days/week outperforms 30 minutes, 2 days/week in every outcome measure.
- Listen to your body: Any increase in pelvic pressure, bleeding, or contractions requires immediate discontinuation and provider consultation.
- Pair with movement: Combine Rubby use with daily walking (minimum 4,500 steps) and anti-inflammatory nutrition (targeting omega-3:omega-6 ratio >1:3).
- Track beyond the app: Log subjective markers—sleep quality, emotional regulation, sexual comfort—in a dedicated journal alongside device metrics.
My final note to families: Your pelvic floor is not broken—it’s adapting. Rubby doesn’t ‘fix’ you. It honors the extraordinary work your body has done and continues to do. By engaging with intentionality and evidence, you reclaim agency in one of the most foundational aspects of reproductive health. That empowerment, rooted in data and dignity, is where true healing begins.
Rubby’s development reflects a broader evolution in perinatal technology—one that prioritizes physiological fidelity over novelty, clinical rigor over influencer hype, and human-centered design over algorithmic convenience. As providers, our role isn’t to endorse products, but to steward information with integrity, ensuring every recommendation aligns with both scientific validity and lived experience. In that light, Rubby stands as a meaningful advancement—not because it’s perfect, but because it meets rigorous standards while remaining accessible, actionable, and deeply respectful of the complexity of pregnancy and postpartum life.
For verified clinical resources, refer to the PeriWell AG Clinical Portal (clinical.periwell.com), the American Physical Therapy Association’s Pelvic Health Section guidelines (https://www.apta.org/pelvichealth), and the Society of Obstetricians and Gynaecologists of Canada’s updated 2023 Pelvic Floor Rehabilitation Position Statement (JOGS 2023;48(3):e112–e125). Always consult your care team before initiating any new pelvic floor intervention.




